BioSpace News Archive

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the second quarter ended June 30, 2018. “Building on the clear direction from our shareholders and a strong conviction in the medical community that BCX7353 is a highly differentiated asset which can deliver enormous value to patients and shareholders, we have made substantial progress advancing our prophylactic and acute BCX7353 clinical progra

Extensive research led to a strategy based on a key truth: Potatoes fuel performance.

Financial release accessible online

Jeffrey Berger, M.D.

Aviva has adopted LINK, Symbility’s collaborative cloud-based platform to improve the claims experience for its UK home and commercial property customers.

The Three Potential Products, If Approved, Will Supplement the Company’s Eight Products Launched in Canada to Date

Based in Miami, Florida, SMP is a high-touch, service-oriented specialty pharmacy that focuses on niche and complex therapeutic areas such as fertility.

Report includes enhanced sections on purchasing and mechanism controls, as well as relevant FDA guidance

$18 million milestone payment received from Shire; Company continues to strengthen cash position from non-dilutive sources

Avanos Medical, Inc. reported second quarter 2018 results, raised its full-year 2018 Medical Device net sales expectations and adjusted diluted earnings per share outlook.